Zeyi Lu

848 total citations
34 papers, 604 citations indexed

About

Zeyi Lu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zeyi Lu has authored 34 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 18 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zeyi Lu's work include MicroRNA in disease regulation (10 papers), RNA modifications and cancer (10 papers) and Circular RNAs in diseases (9 papers). Zeyi Lu is often cited by papers focused on MicroRNA in disease regulation (10 papers), RNA modifications and cancer (10 papers) and Circular RNAs in diseases (9 papers). Zeyi Lu collaborates with scholars based in China, Germany and Australia. Zeyi Lu's co-authors include Gonghui Li, Liqun Xia, Lifeng Ding, Qiming Zheng, Ruyue Wang, Danyang Shen, Huan Wang, Dingwei Xue, Haiyun Xie and Sheng Cheng and has published in prestigious journals such as ACS Nano, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Zeyi Lu

32 papers receiving 599 citations

Peers

Zeyi Lu

PRM

ONCOL

Guozheng Guo China

Ming-Teh Chen Taiwan

Xuhui Yang China

Xiaoning Lin China

Amir Barzegar Behrooz Iran

Céline S. Gonçalves Portugal

Laura Rosanò Italy

Seoyeon Bok South Korea

Ziwen Pan China

Kaiyan Xi China

Guozheng Guo China

Zeyi Lu

363 ×0.9

192 ×0.7

85 ×0.9

PRM

136 ×2.2

ONCOL

23 ×0.4

Citations per year, relative to Zeyi Lu Zeyi Lu (= 1×) peers Guozheng Guo

Countries citing papers authored by Zeyi Lu

Since Specialization

Citations

This map shows the geographic impact of Zeyi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeyi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeyi Lu more than expected).

Fields of papers citing papers by Zeyi Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeyi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeyi Lu. The network helps show where Zeyi Lu may publish in the future.

Co-authorship network of co-authors of Zeyi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Zeyi Lu. A scholar is included among the top collaborators of Zeyi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeyi Lu. Zeyi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yuhuang, Jiayi Li, Zeyi Lu, et al.. (2025). High-Definition, Video-Rate Triple-Channel NIR-II Imaging Using Shadowless Lamp Excitation and Illumination. ACS Nano. 19(1). 1743–1756. 3 indexed citations

Wang, Ruyue, Fan Li, Zeyi Lu, et al.. (2025). piR‐RCC Suppresses Renal Cell Carcinoma Progression by Facilitating YBX‐1 Cytoplasm Localization. Advanced Science. 12(30). e14398–e14398.

Xu, Li, Xudong Mao, Yiming Ding, et al.. (2025). Conditional survival analysis and real-time prognosis prediction for prostate cancer patients. Scientific Reports. 15(1). 18711–18711. 1 indexed citations

Ma, Jing, Yiming Ding, Zeyi Lu, et al.. (2025). Integrated multi-omics analysis identifies a machine learning-derived signature for predicting prognosis and therapeutic vulnerability in clear cell renal cell carcinoma. Life Sciences. 363. 123396–123396. 1 indexed citations

Lu, Zeyi, et al.. (2024). Least-Squares Algorithms for Complex-Valued Blind Source Separation. Circuits Systems and Signal Processing. 43(4). 2608–2625.

Luo, Wenqin, Fan Li, Lifeng Ding, et al.. (2024). m6Am Methyltransferase PCIF1 Promotes LPP3 Mediated Phosphatidic Acid Metabolism and Renal Cell Carcinoma Progression. Advanced Science. 11(46). e2404033–e2404033. 4 indexed citations

Luo, Wenqin, Huan Wang, Zeyi Lu, et al.. (2023). HIF1A-repressed PUS10 regulates NUDC/Cofilin1 dependent renal cell carcinoma migration by promoting the maturation of miR-194-5p. Cell & Bioscience. 13(1). 153–153. 6 indexed citations

Yu, Hao, Cheng Wang, Lingyun Wu, et al.. (2023). A novel hydrogel orthotopic injection model in moderately hypofractionated radiation therapy for prostate cancer: Adaptive degradation and durable imaging. Frontiers in Oncology. 12. 1077900–1077900. 5 indexed citations

Li, Yang, Zeyi Lu, Qiming Zheng, et al.. (2023). Comprehensive analysis of subtypes and risk model based on complement system associated genes in ccRCC. Cellular Signalling. 111. 110888–110888. 2 indexed citations

10.

Chen, Yuanlei, Zeyi Lu, Chao Qi, et al.. (2022). N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma. Molecular Cancer. 21(1). 111–111. 78 indexed citations

11.

Xie, Haiyun, Mingchao Wang, Huan Wang, et al.. (2022). METTL1 drives tumor progression of bladder cancer via degrading ATF3 mRNA in an m7G-modified miR-760-dependent manner. Cell Death Discovery. 8(1). 458–458. 25 indexed citations

12.

Ding, Lifeng, Ruyue Wang, Qiming Zheng, et al.. (2022). circPDE5A regulates prostate cancer metastasis via controlling WTAP-dependent N6-methyladenisine methylation of EIF3C mRNA. Journal of Experimental & Clinical Cancer Research. 41(1). 187–187. 50 indexed citations

13.

Ren, Liangliang, Minxiao Jiang, Dingwei Xue, et al.. (2022). Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway. International Journal of Biological Sciences. 18(13). 5207–5220. 20 indexed citations

14.

Shen, Danyang, Lifeng Ding, Zeyi Lu, et al.. (2021). METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination. Molecular Therapy — Nucleic Acids. 27. 547–561. 46 indexed citations

15.

Xu, Liwei, Zeyi Lu, Shicheng Yu, Gonghui Li, & Yuanlei Chen. (2021). Quantitative global proteome and phosphorylome analyses reveal potential biomarkers in kidney cancer. Oncology Reports. 46(5). 8 indexed citations

16.

Ding, Lifeng, Ruyue Wang, Danyang Shen, et al.. (2021). Role of noncoding RNA in drug resistance of prostate cancer. Cell Death and Disease. 12(6). 590–590. 50 indexed citations

17.

Zheng, Qiming, Zeyi Lu, Liya Wang, et al.. (2021). Role of the nervous system in cancers: a review. Cell Death Discovery. 7(1). 76–76. 99 indexed citations

18.

Ding, Lifeng, Minxiao Jiang, Ruyue Wang, et al.. (2020). The emerging role of small non-coding RNA in renal cell carcinoma. Translational Oncology. 14(1). 100974–100974. 13 indexed citations

19.

Wang, Huan, Zhongyi Li, Yuanlei Chen, et al.. (2020). The prognostic value of miRNA-18a-5p in clear cell renal cell carcinoma and its function via the miRNA-18a-5p/HIF1A/PVT1 pathway. Journal of Cancer. 11(10). 2737–2748. 12 indexed citations

20.

Chen, Yuanlei, Zeyi Lu, Dingwei Xue, et al.. (2019). Development and verification of a nomogram for prediction of recurrence‐free survival in clear cell renal cell carcinoma. Journal of Cellular and Molecular Medicine. 24(2). 1245–1255. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact